The STELLAR research trial found that a new combination therapy improved survival rates for patients with grade 3 astrocytoma, an aggressive form of brain cancer.
Three decades after his mother passed away from pancreatic cancer, Russ faced the same diagnosis at the same age. But a groundbreaking clinical trial is helping his story unfold differently.
The medical director of the Clinical Trials Office shares what sets Huntsman Cancer Institute apart, the importance of specialized care, and why she loves interacting with patients.
Two physician-scientists at Huntsman Cancer Institute have been named 2026 Translational Scholars, recognizing their leadership in advancing translational research that brings scientific discoveries to cancer patients faster.
A clinical trial led by Neeraj Agarwal, MD, FASCO, found that a combination prostate cancer therapy could slow disease progression for patients with certain gene alterations, including BRCA.
Skyler Johnson, MD, became an oncologist and researcher after cancer impacted his family. Today, he helps patients through evidence-based treatment, combating misinformation, and reducing uncertainty with clarity and hope.
Malani reflects on how Huntsman Cancer Institute emphasizes patient care, innovative clinical trials, and collaborative research to improve brain cancer treatments and provide hope for patients and families.
A recent study found that glioblastoma patients living farther from specialized centers have lower clinical trial participation and slightly worse survival rates, highlighting the need to expand access.
Robotic surgery for bladder cancer reduces complications and blood clot risks, especially during radical cystectomy, leading to improved outcomes and a better overall experience for patients undergoing bladder removal.
Charlene Edwards was diagnosed with neuroendocrine cancer in 2005. She continues to find hope in treatment innovations like theranostics, a form of targeted radiation that seeks and destroys cancer cells.
Huntsman Cancer Institute has appointed experienced leaders to guide its growing research and clinical program in theranostics, a promising new way to find and treat cancer.
New research shows regular exercise may change how colon cancer behaves at a molecular level, altering genes in tumors and fat tissue—highlighting the deep impact of movement on health.
New drug therapy gives hope to advanced melanoma patients, personalized exercise plans enhance lung cancer patient recovery, and patient receives first allogeneic stem cell transplant from a deceased organ donor.
